article_metadata: Tanja Lepir Mehdi Zaghouani Stéphane P Roche Ying-Ying Li Miguel Suarez Maria Jose Irias Niramol Savaraj
article_metadata: 10.1097/MD.0000000000013804
article_metadata: Medicine (Baltimore)
article_metadata: 2019 Jan;98(2):e13804.
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/30633154/
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Head and Neck Neoplasms / drug therapy Melanoma / drug therapy Nivolumab / therapeutic use
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Head and Neck Neoplasms / drug therapy Melanoma / drug therapy Nivolumab / therapeutic use Case Reports Aged Combined Modality Therapy Disease Progression Drug Substitution Head and Neck Neoplasms / diagnostic imaging Head and Neck Neoplasms / pathology Humans Male Melanoma / diagnostic imaging Melanoma / pathology Retreatment Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological Nivolumab pembrolizumab
article_metadata: PMC6336603
article_metadata: 30633154
article_metadata: Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report
article_metadata: 2019